Viva Biotech Holdings (01873) Announces Monthly Return on Share Capital Movements for October 2025

Bulletin Express

Nov 05

Viva Biotech Holdings reported no change in its authorized share capital, which remains at 4,000,000,000 ordinary shares with a par value of USD 0.000025 each, totaling USD 100,000.

The number of issued shares (excluding treasury shares) increased from 2,128,434,305 to 2,129,882,353 during October 2025. This change primarily arose from the exercise of 1,448,048 share options under a pre-IPO share incentive scheme, raising USD 178,156.24.

Following the exercise, 2,217,093 share options remained outstanding under the pre-IPO share incentive scheme. The post-IPO share option scheme continued to show 9,620,000 outstanding share options, without changes. No treasury shares were involved in any transaction during the period.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1158911208"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1158911208\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1158911208?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-05 15:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1158911208","market":"us","top_or_hot":-1,"title":"Viva Biotech Holdings (01873) Announces Monthly Return on Share Capital Movements for October 2025","media":"Bulletin Express","content":"<p>Viva Biotech Holdings reported no change in its authorized share capital, which remains at 4,000,000,000 ordinary shares with a par value of USD 0.000025 each, totaling USD 100,000.</p>\n<p>The number of issued shares (excluding treasury shares) increased from 2,128,434,305 to 2,129,882,353 during October 2025. This change primarily arose from the exercise of 1,448,048 share options under a pre-IPO share incentive scheme, raising USD 178,156.24.</p>\n<p>Following the exercise, 2,217,093 share options remained outstanding under the pre-IPO share incentive scheme. The post-IPO share option scheme continued to show 9,620,000 outstanding share options, without changes. No treasury shares were involved in any transaction during the period.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Viva Biotech Holdings (01873) Announces Monthly Return on Share Capital Movements for October 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nViva Biotech Holdings (01873) Announces Monthly Return on Share Capital Movements for October 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-05 15:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Viva Biotech Holdings reported no change in its authorized share capital, which remains at 4,000,000,000 ordinary shares with a par value of USD 0.000025 each, totaling USD 100,000.</p>\n<p>The number of issued shares (excluding treasury shares) increased from 2,128,434,305 to 2,129,882,353 during October 2025. This change primarily arose from the exercise of 1,448,048 share options under a pre-IPO share incentive scheme, raising USD 178,156.24.</p>\n<p>Following the exercise, 2,217,093 share options remained outstanding under the pre-IPO share incentive scheme. The post-IPO share option scheme continued to show 9,620,000 outstanding share options, without changes. No treasury shares were involved in any transaction during the period.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01873","symbol_name":"维亚生物","start_time":0,"source_url":"","article_id":"1158911208","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1158911208","pubTimestamp":1762327310,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Viva Biotech Holdings reported no change in its authorized share capital, which remains at 4,000,000,000 ordinary shares with a par value of USD 0.000025 each, totaling USD 100,000. The number of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01873":"维亚生物"},"translate_title":"维亚生物控股(01873)公布2025年10月之股本变动月报表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01873":1},"content_text":"Viva Biotech Holdings reported no change in its authorized share capital, which remains at 4,000,000,000 ordinary shares with a par value of USD 0.000025 each, totaling USD 100,000.\nThe number of issued shares (excluding treasury shares) increased from 2,128,434,305 to 2,129,882,353 during October 2025. This change primarily arose from the exercise of 1,448,048 share options under a pre-IPO share incentive scheme, raising USD 178,156.24.\nFollowing the exercise, 2,217,093 share options remained outstanding under the pre-IPO share incentive scheme. The post-IPO share option scheme continued to show 9,620,000 outstanding share options, without changes. No treasury shares were involved in any transaction during the period.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}